Mortality in Parkinson's disease: A systematic review and meta‐analysis

Macleod, Angus D., Taylor, Kate S.M., Counsell, Carl E.·2014·Movement Disorders
DOI 10.1002/mds.25898

Cited by (331)

Items 301–331 of 331

  1. Linear predictive coding electroencephalography algorithms predict mortality in Parkinson’s disease
    Simin Jamshidi, Arturo I. Espinoza, Jonathan T. Heinzman, Patrick May, Ergun Y. Uc, Nandakumar S. Narayanan, Soura Dasgupta · 2025 · Clinical Parkinsonism & Related Disorders
  2. Additional file 1 of Occupational pesticide exposure and the risk of death in patients with Parkinson’s disease: an observational study in southern Brazil
    Schneider Medeiros, Márcio, P. Reddy, Sumanth, P. Socal, Mariana, Artur Francisco Schumacher‐Schuh, Mello Rieder, Carlos Roberto · 2020 · Figshare
  3. Additional file 1 of Psychometric properties of Arabic-translated-related quality of life scales for people with parkinson disease: a scoping review
    Chiraz Azaiez, Naser Chalghaf, Tannoubi, Amayra, Noomen Guelmami, Medina Srem‐Sai, Frank Quansah, John Elvis Hagan, Heifa Sneni, Ghada Boussayala, Imane Ghalmi et al. · 2024 · Figshare
  4. Additional file 1 of Tinetti balance performance is associated with mortality in older adults with late-onset Parkinson’s disease: a longitudinal study
    Laurent, Louise, Pierre Koskas, Janina Estrada, Mélanie Sebbagh, Sophie Lacaille, Agathe Raynaud-Simon, Matthieu Lilamand · 2023 · Figshare
  5. Additional file 1 of Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
    Maresova, Petra, Lukáš Režný, Petr Bauer, Valko, Marian, Kuca, Kamil · 2024 · Figshare
  6. Additional file 1 of Survival in patients with Parkinson’s disease: a ten-year follow-up study in northern China
    Wang, Song, Li, Tao, Zhou, Tingting, Lanlan Pu, Wang, Hai-Yang, Yin, Xiaoxue, Hao, Xinqing, Lu Ren, Zhanhua Liang · 2022 · Figshare
  7. Additional file 2 of Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
    Maresova, Petra, Lukáš Režný, Petr Bauer, Valko, Marian, Kuca, Kamil · 2024 · Figshare
  8. Additional file 1 of Classification of long-term clinical course of Parkinson’s disease using clustering algorithms on social support registry database
    Dougho Park, Lee, Su Yun, Kim, Jong Hun, Kim, Hyoung Seop · 2023 · Figshare
  9. Additional file 3 of Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
    Maresova, Petra, Lukáš Režný, Petr Bauer, Valko, Marian, Kuca, Kamil · 2024 · Figshare
  10. Additional file 4 of Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
    Maresova, Petra, Lukáš Režný, Petr Bauer, Valko, Marian, Kuca, Kamil · 2024 · Figshare
  11. Maladie de Parkinson : physiopathologie, critères diagnostiques et signes cliniques
    A. Marques · 2025 · Encyclopédie médico-chirurgicale. Neurologie
  12. Should Neurogenic Supine Hypertension Be Treated? Insights from Hypertension-Mediated Organ Damage Studies—A Narrative Review
    Cristiano Fava, Federica Stocchetti, Sara Bonafini · 2025 · Biomedicines
  13. Impact of type 2 diabetes on the development of dementia and death in Parkinson's disease
    Seung Hyun Lee, Jooyoung Lee, Mina Kim, D. H. Kim, Yun Su Hwang, Kye Won Park, Sungyang Jo, Ji‐Hoon Kang, Richard J. Cook, S R Chung · 2026 · Parkinsonism & Related Disorders
  14. Survival and related factors in patients with Parkinson's disease: a multicenter prospective cohort study in China
    Tingwei Song, Linghui Xiang, Y Liu, Hongxu Pan, Yiting Wu, Yu Liu, Fei Luo, Chunyu Wang, Lifang Lei, Lingyan Yao et al. · 2026 · Journal of Neurology
  15. Diseases of the Nervous System
    Dávid Brenner · 2026 · Springer eBooks
  16. Life-course influence of birthweight and subsequent pathways on healthy aging: a Mendelian randomization study
    Lijie Kong, Chun Dou, Chaojie Ye, Dong Liu, Mingling Chen, Jie Zheng, Min Xu, Yu Xu, Mian Li, Zhiyun Zhao et al. · 2026 · BMC Medicine
  17. La dysarthrie dans la maladie de Parkinson : corrélats physiologiques, cognitifs et fonctionnels
    Cyril Atkinson-Clément · 2017
  18. Dysrythmie dans la maladie de Parkinson : le jeu sérieux comme remédiation des troubles de la coordination
    Frédéric Puyjarinet · 2019 · theses.fr (ABES)
  19. Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila
    Xiaojing Yue · 2022 · theses.fr (ABES)
  20. Bases neuro-fonctionnelles des troubles de l’impulsivité dans la maladie de Parkinson
    Garance M. Meyer · 2022 · theses.fr (ABES)
  21. Analyse des dynamiques et processus dyadiques sous-jacents à l'expérience du couple confronté à une maladie neuroévolutive
    Charlotte Manceau · 2024
  22. Impacts de la modulation du cholestérol cérébral dans la maladie de Parkinson
    Lisa Rousselot · 2023 · theses.fr (ABES)
  23. Morbo di Parkinson: fisiopatologia, criteri diagnostici e segni clinici
    A. Marques · 2026 · EMC - Neurologia
  24. Cumulative environmental burden and neurodegenerative disease mortality: a national ecological study in the United States
    Guoli Ma, Yu Shi, Junlan Qiu, Chao Ren, Konglan Shao, Xiaochen Shu · 2026 · American Journal of Epidemiology
  25. Comorbidities and Complications in Parkinson’s Disease in Primary Care
    Olaitan Okunoye, Laura Horsfall, Louise Marston, Kate R Walters, Anette E. Schrag · 2026 · European Journal of Neurology
  26. Device aided therapies in Parkinson disease: an expert view on apomorphine
    Fabrizio Stocchi, Roberto Ceravolo, Carlo Colosimo, Maria Francesca De Pandis, Nicola Modugno, Manuela Pilleri, Alessandro Tessitore, Michèle Tinazzi, Franco Valzania, Carmine Vitale et al. · 2026 · Neurological Sciences
  27. The influence of cholesterol on the 5-year all-cause mortality of Parkinson patients with or without deep brain stimulation
    Gabriel C. Roth, Marco Treven, Christof Brücke, Johann P. Lehrner · 2026 · Science Progress
  28. Prognostic factors of survival in corticobasal syndrome and corticobasal degeneration: A scoping review
    Muhammad S. Saim, Hayder Al-Kazzaz, Haris Ahmad · 2026 · Neurological Sciences
  29. Advanced therapeutic strategies in Parkinson’s disease: From molecular pathomechanisms to precision drug delivery
    Roumodip Adak, Pushpendra Kumar, Shreyash Santosh Yadav, Sandeep Chaudhary, Ashok Kumar Datusalia · 2026 · Advances in pharmacology
  30. The Effect of LRRK2 and GBA1 Mutations on Survival in Early‐ and Late‐Onset Parkinson's Disease
    Raz Rubin, Roy N. Alcalay, Nurit Omer, Orly Goldstein, Mali Gana‐Weisz, Anat Mirelman, Avner Thaler · 2026 · Movement Disorders
  31. Parkinson’s disease and chronic kidney disease trends and disparities in the US population aged over 25 years (1999–2023)
    Raymond Haward, Nikhil Duseja, Harkanwar Sandhu, Shankar Biswas, Jai Kumar Rajavoor Muniswamy, Mobeen Abid, Pooja Prasad, Newton Ashish Shah, Rutvik Jadvani, Iswariya Mani et al. · 2026 · Medicine